MolNFT v1 · #37058 · protein
Human carbonic anhydrase I complexed with a two-prong inhibitor
2FOY · Carbonic anhydrase 1: “Human carbonic anhydrase I complexed with a two-prong inhibitor”. X-ray diffraction, 2 ligands (B30, ZN), 2 pockets (best druggability 0.85). MolNFT v1 #37058 on GenesisL1: 3D structure, binding sites and…
- PDB
- 2FOY
- Type
- protein
- Length
- 513 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Carbonic anhydrase 1
- EC
- 4.2.1.1
- UniProt
- P00915
- Ligands
- B30, ZN
- Pockets
- 2 · best druggability 0.85
Structure
x-ray diffraction · 2 distinct chains · 17% helix, 30% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Carbonic anhydrase 1 (EC 4.2.1.1) | protein | 256 | 16% helix, 30% strand | P00915 |
| B | Carbonic anhydrase 1 (EC 4.2.1.1) | protein | 257 | 17% helix, 30% strand | P00915 |
Ligands and binding sites
- B30 · {2,2'-[(2-{[4-(aminosulfonyl)benzoyl]amino}ethyl)imino]diacetato(2-)-kappao}copper · ligand · 6 copies · chains A, B
- ZN · Zinc ion · metal · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1078 | 0.85 | 0.86 | 100 | B30 |
| 2 | 56 | 0.27 | 0.73 | 16 | empty |
Interfaces
1 interface between chains.
- A–B · 500 Ų buried · 10 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00915
- Elsewhere: RCSB PDB 2FOY · PDBe 2FOY · UniProt P00915
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.